MyMD Pharmaceuticals (MYMD) Stock Price, News & Analysis
Company Description
MyMD Pharmaceuticals (NASDAQ: MYMD) is classified in the pharmaceutical preparation manufacturing industry within the In Vitro & in Vivo Diagnostic Substances sector and carries a market capitalization of $4.3M, ranking #7,019 among all listed U.S. companies by market cap.
MYMD has declined 93.8% over the past year. Shares last traded at $1.82.
This page collects what Stock Titan holds for MYMD, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
MyMD Pharmaceuticals (MYMD) stock last closed at $1.82. Over the past 12 months, the stock has lost 93.8%. At a market capitalization of $4.3M, MYMD is classified as a micro-cap stock.
MYMD Rankings
Latest News
MyMD Pharmaceuticals has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 5 with negative movement. Key topics include clinical trial, management, stock split. View all MYMD news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
MYMD Company Profile & Sector Positioning
MyMD Pharmaceuticals (MYMD) operates in the Pharmaceutical Preparation Manufacturing industry within the broader In Vitro & in Vivo Diagnostic Substances sector and is listed on the NASDAQ.